NanoVibronix has filed a notice of an exempt offering of securities to raise $13,546,513.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, NanoVibronix is raising $13,546,513.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brian Murphy played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About NanoVibronix
NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low intensity acoustic technology. The company’s patented technology allows for creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible material surfaces. This unique development may be utilized for a variety of medical requiring low cost therapeutic ultrasound applications. The company’s patch based product diagnosis, PainShield, carries an FDA clearance. NanoVibronix catheter based products include the CathbotTM . NanoVibronix Inc. is located in Elmsford, NY. Its subsidiary, NanoVibronix Ltd. is located in Nesher, Israel.
To learn more about NanoVibronix, visit http://www.nanovibronix.com/
Contact:
Brian Murphy, Chief Executive Officer
914-233-3004
https://www.linkedin.com/in/brianmurphynano/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.